The Nomination Committee of BICO Group AB today announces the proposal of Rolf Classon to the Annual General Meeting as the company’s new Chairman of the Board. Rolf Classon has been a board member of BICO Group AB since April 2022. Rolf Classon is a seasoned leader in the healthcare industry, having held numerous high-ranking positions in life science companies throughout the years. He currently serves as Vice Chairman of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA, Chairman of Hill-Rom Holdings Inc., as well as a member of the Board of Directors of Catalent Inc. Throughout his career, Mr. Classon has served as Chairman of the Board of Directors in Tecan Group Ltd., Swedish Orphan International, and Chairman of the Executive Committee of Bayer HealthCare AG, and member of the Board of Directors for Millipore Corporation.

The present Chairman of the Board, Carsten Browall, has declined re-election at the 2023 Annual General Meeting.

“We are very pleased to propose Rolf Classon as the new Chairman of the Board at BICO Group. We also want to take this opportunity to thank Carsten Browall for his foremost work for the Board of Directors and BICO’s growth journey since 2018.”

Malin Björkmo, Chairman of the Nomination Committee, BICO Group AB

The Nomination Committee will present its complete proposal and reasoned statement in connection with the invitation to the 2023 annual general meeting.

For more information please contact:
Malin Björkmo, Chairman of the Nomination Committee
Mobile phone: +46 705-88 99 63
Email: malin@bjorkmoadvisors.se

Åsa Hillsten, Senior Advisor Investor Relations, BICO Group AB
Phone: +46 70-081 81 17
Email: ash@bico.com